Inactive Instrument
IRLAB Therapeutics AB Share Price Nasdaq Stockholm
Stocks
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Nasdaq Stockholm
|
||
| - SEK | - |
|
| 09-03 | Irlab CEO Kristina Torfgaard to step down in 2027 | FW |
| 09-03 | Irlab CEO Kristina Torfgaard wants to step down | FW |
| Market Cap | 272M 27.16M 23.95M 22.66M 20.46M 38.63M 2.6B 39.08M 104M 1.33B 102M 99.72M 4.3B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 272M 27.16M 23.95M 22.66M 20.46M 38.63M 2.6B 39.08M 104M 1.33B 102M 99.72M 4.3B | EV / Sales 2026 * |
2.68x | EV / Sales 2027 * | 1.9x |
| Free-Float |
83.4% | Yield 2026 * |
-
| Yield 2027 * | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 31/07/2024 | |
Susanna Waters
PRN | Corporate Officer/Principal | 60 | 31/12/2012 |
Clas Sonesson
CTO | Chief Tech/Sci/R&D Officer | 65 | 31/12/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Rein Piir
BRD | Director/Board Member | 68 | 31/12/2015 |
| Chairman | 73 | 06/05/2020 | |
Veronica Wallin
BRD | Director/Board Member | 40 | 31/12/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.33% | -1.12% | +59.27% | +115.42% | 1,056B | |
| -1.06% | -1.65% | +45.77% | +69.98% | 645B | |
| -0.65% | -1.36% | +17.22% | +75.49% | 465B | |
| -2.66% | -3.71% | +84.92% | +41.15% | 368B | |
| -0.06% | -4.12% | +36.31% | +39.39% | 335B | |
| -0.79% | +3.01% | +21.11% | +27.79% | 275B | |
| -1.19% | -3.09% | +10.75% | +10.61% | 255B | |
| -0.50% | +2.75% | +53.85% | +56.84% | 229B | |
| -1.47% | -2.37% | +32.35% | +98.89% | 188B | |
| Average | -0.25% | +0.12% | +40.17% | +59.51% | 423.98B | |
| Weighted average by Cap. | -0.05% | +0.30% | +44.68% | +71.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 101M 10.12M 8.93M 8.45M 7.62M 14.4M 970M 14.57M 38.91M 496M 37.99M 37.16M 1.6B | 143M 14.32M 12.63M 11.95M 10.79M 20.37M 1.37B 20.61M 55.06M 702M 53.76M 52.59M 2.27B |
| Net income | -36.1M -3.61M -3.18M -3.01M -2.72M -5.14M -346M -5.2M -13.88M -177M -13.55M -13.26M -572M | 34.6M 3.46M 3.05M 2.89M 2.61M 4.92M 332M 4.98M 13.3M 170M 12.99M 12.71M 548M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
Calendar
Select your edition
All financial news and data tailored to specific country editions
